Metformin Treatment of Patients with Hand Osteoarthritis

PHASE3RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

April 30, 2026

Conditions
Hand Osteoarthritis
Interventions
DRUG

Metformin

Metformin will be initiated at 500 mg once daily with breakfast meal. The dose will be increased with 500 mg every week until 2 g/day is reached, distributed as 1000 mg every morning and evening, together with a meal. If the subject cannot tolerate the maximum dose (2 g/day), the maximal tolerated dose will be given. The treatment period including titration is 16 weeks.

DRUG

Placebo

Participants in the placebo group will receive a placebo tablet identical to the metformin tablet

Trial Locations (1)

2000

RECRUITING

The Parker Institute, Bispebjerg and Frederiksberg hospital, Copenhagen

All Listed Sponsors
lead

Marius Henriksen

OTHER